Despite all recent progress, cancer remains one of the deadliest human diseases. In a new publication that appeared in the journal Cell, researchers from Jürgen Knoblich's lab at IMBA – Institute of Molecular Biotechnology of the Austrian Academy of…

LifeTime, which counts Jürgen Knoblich, scientific director at IMBA, as a leading member, has developed a strategy to integrate breakthrough-technologies that will further develop personalised treatment for cancer, cardiovascular and metabolic…

A team of researchers, spearheaded by the Gerlich lab at IMBA, has uncovered how cells remove unwanted components from the nucleus following mitosis. The results, published in the journal Nature, stem from a fruitful collaboration between the Gerlich…

HCA|Organoid is a new EU research project that combines single-cell profiling and organoid technology to validate organoids as faithful models of human biology. The project seeks to kickstart the development of an open access “Organoid Cell Atlas”.

The new start-up QUANTRO Therapeutics at the Vienna BioCenter uses innovative transcriptome profiling technologies in a novel drug discovery pipeline to identify and develop effective anti-tumor therapeutics. The company is a spin-off resulting from…

The establishment of self-organizing heart organoids called cardioids, at IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – has the potential to revolutionize research into cardiovascular disorders and congenital heart…

An important pillar in the fight against the Covid-19 pandemic is accurate, rapid and frequent testing for the coronavirus SARS-CoV-2, for example, the real-time qPCR method, in which the viral nucleic acid molecules in samples taken from nasal and…

On Thursday a special visit to the IMBA and the Vienna Open Lab presented the most important cornerstones of the new Research Funding Act. Anton Zeilinger, President of the Austrian Academy of Sciences, welcomed Minister of Science Heinz Faßmann…

Jürgen Knoblich, Scientific Director of IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – is now part of the Board of Directors of the ISSCR, the renowned International Society for Stem Cell Research. Knoblich will…

An international team of researchers with the participation of IMBA - Institute of Molecular Biotechnology of the Austrian Academy of Sciences - reports the discovery of a thinness gene - ALK – conserved in evolution from flies to mice and…